Identification of a Novel Subset of Human Airway Epithelial Basal Stem Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25189863 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Christopher Cheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Oregon Stem Cell Center, Papè Family Pediatric Research Institute, Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239…. Hauptthemen laut MEDLINE: Stem Cells, Cell Differentiation, Keratin-5, Epithelial Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, Oregon Health & Science University.
Abstract (Originalsprache)
The basal cell maintains the airway’s respiratory epithelium as the putative resident stem cell. Basal cells are known to self-renew and differentiate into airway ciliated and secretory cells. However, it is not clear if every basal cell functions as a stem cell. To address functional heterogeneity amongst the basal cell population, we developed a novel monoclonal antibody, HLO1-6H5, that identifies a subset of KRT5+ (cytokeratin 5) basal cells. We used HLO1-6H5 and other known basal cell-reactive reagents to isolate viable airway subsets from primary human airway epithelium by Fluorescence Activated Cell Sorting. Isolated primary cell subsets were assessed for the stem cell capabilities of self-renewal and differentiation in the bronchosphere assay, which revealed that bipotent stem cells were, at minimum 3-fold enriched in the HLO1-6H5+ cell subset. Crosslinking-mass spectrometry identified the HLO1-6H5 target as a glycosylated TFRC/CD71 (transferrin receptor) proteoform. The HLO1-6H5 antibody provides a valuable new tool for identifying and isolating a subset of primary human airway basal cells that are substantially enriched for bipotent stem/progenitor cells and reveals TFRC as a defining surface marker for this novel cell subset.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oregon Stem Cell Center, Papè Family Pediatric Research Institute, Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239-3098, USA.
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239-3098, USA.
- Marsico Lung Institute/Cystic Fibrosis Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7248, USA.
ORCID-Profile: Christopher Cheng, Matthew E K Chang, Mark R Flory, Scott H Randell
Förderung
- NEI NIH HHS
- NIH HHS
- Oregon Health & Science University
- Cystic Fibrosis Foundation
- NHLBI NIH HHS
- NCRR NIH HHS
- NCI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Cheng, C., Katoch, P., Zhong, Y. P., Higgins, C. T., Moredock, M., Chang, M. E. K., Flory, M. R., Randell, S. H., & Streeter, P. R. (2024). Identification of a Novel Subset of Human Airway Epithelial Basal Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25189863
Vancouver
Cheng C, Katoch P, Zhong YP, Higgins CT, Moredock M, Chang MEK, et al. Identification of a Novel Subset of Human Airway Epithelial Basal Stem Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25189863
BibTeX
@article{Cheng2024,
author = {Cheng, Christopher and Katoch, Parul and Zhong, Yong-Ping and Higgins, Claire T and Moredock, Maria and Chang, Matthew E K and Flory, Mark R and Randell, Scott H and Streeter, Philip R},
title = {Identification of a Novel Subset of Human Airway Epithelial Basal Stem Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25189863}
}
EUVIMED